Background Anaemia associated with cancer and cancer therapy is an important clinical
factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant …

Fatigue is an exceedingly common often treatable problem in cancer patients that
profoundly affects all aspects of quality of life. Prevalence estimates have ranged from 50 …

Purpose Radiotherapy for prostate cancer (PCa) may cause unfavorable changes in fatigue,
quality of life (QOL), and physical fitness. We report results from the Prostate Cancer …

Background Erythropoiesis‐stimulating agents (ESAs) reduce anemia in cancer patients
and may improve quality of life, but there are concerns that ESAs might increase mortality …

Cancer-related fatigue is the most prevalent cancer symptom, reported in 50%-90% of
patients and severely impacts quality of life and functional capacity. The condition remains …

Background: Our objective was to determine whether, compared with control interventions,
pharmacologic interventions reduce the severity of fatigue in patients with cancer or …

Fatigue is the most commonly reported symptom in patients with cancer, with a prevalence
of over 60% reported in the majority of studies. This paper systematically reviews …

Introduction Treatment advances in multiple myeloma have increased expected survival
from months to years for some patients. Alongside improved survival emerges a need to …

A fadiga relacionada ao câncer (FRC) é um dos sintomas mais prevalentes em pacientes
com câncer, sendo reportada por 50% a 90% dos pacientes durante o curso da doença ou …

The study explored the experience of fatigue, its effects and ways of coping with fatigue and
the role of family and social support among breast cancer patients. In-depth, semi-structured …